Ain Holdings Inc. · TSE:9627

Ain — FY4/22 Earnings Presentation

26 slides from Ain's earnings presentation, June 2022

  1. Slide 1: FY4/22 IR Presentation

    FY4/22 IR PRESENTATION June 2022

  2. Slide 2: Results Overview

    Results Overview © 2022 AIN HOLDINGS INC. All Rights Reserved. 1

  3. Slide 3: Consolidated P/L

    Consolidated P/L Net sales increased 6.4% YoY and 0.4% against the plan due to increase of sales in dispensing pharmacy business, despite the impact of the COVID-19. Ordinary profit increased 26.8% YoY and 3.5% against the plan due to increase of sales. FY4/21 FY4/22 FY4/22 YoY YoY Vs plan （¥ millio

  4. Slide 4: Dispensing Pharmacy Business (Consolidated)

    Dispensing Pharmacy Business (Consolidated) Net sales increased 7.6% YoY and 2.5% against the plan due to the recovery in prescription volume at existing stores and the contribution of stores opened in previous year. Segment profit increased 19.7% YoY and 10.5% against the plan due to increase of sa

  5. Slide 5: Cosmetic and Drug Store Business (Consolidated)

    Cosmetic and Drug Store Business (Consolidated) Net sales up 5.9% YoY and declined 17.8% against the plan due to the recovery of existing stores and contribution of stores opened in previous year despite the impact of the COVID-19. Segment loss was ¥1,764 million, ¥1,094 million below the plan. FY4/

  6. Slide 6: Consolidated B/S

    Consolidated B/S Net cash became ¥51,238 million and shareholders’ equity ratio became 56.0%. We are maintaining a sound financial structure even during the COVID-19 outbreak. End-FY4/21 (¥ million) End-FY4/22 (¥ million) Assets Liabilities Assets Liabilities Current assets Current 74,160 Current as

  7. Slide 7: Assets

    Assets The balance of total assets increased ¥8,799 million from the end of the previous fiscal year due to increase of cash on hand and in banks. (¥ million) End-FY4/20 End-FY4/21 End-FY4/22 Change Cash on hand and in banks 46,321 55,271 59,729 +4,458 Notes and accounts receivable 13,653 13,475 10,

  8. Slide 8: Liabilities and Net Assets

    Liabilities and Net Assets Accounts payable increased ¥3,998 million due to the increased purchases from new store openings and M&A. Short-term and long-term debt decreased ¥3,509 million due to repayment. (¥ million) End-FY4/20 End-FY4/21 End-FY4/22 Change Accounts payable 47,187 46,758 50,756 +3,9

  9. Slide 9: Consolidated C/F

    Consolidated C/F Operating activities was ¥26,156 million due to active new store opening especially focus on large- scale store. Cash and cash equivalents at the end of the quarter were ample, up ¥4,461 million from the previous fiscal year. (¥ million) FY4/21 FY4/22 Change Net cash provided by ope

  10. Slide 10: Business Value Analysis

    Business Value Analysis FY4/20 FY4/21 FY4/22 Change Shareholders’ equity ratio (%) 57.3 56.8 56.0 (0.8) Market value equity ratio (%) 110.4 105.6 96.6 (9.0) PER (times) 23.27 32.11 28.99 (3.12) EPS (¥) 259.11 189.04 201.47 +12.43 PBR (times) 1.92 1.86 1.74 (0.12) BPS (¥) 3,130.77 3,267.49 3,385.51 +

  11. Slide 11: FY4/23 Plan (Consolidated)

    FY4/23 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2023 of ¥363,000 million, increase 14.8% YoY and ordinary profit of ¥20,500 million, increase 27.8% YoY. FY4/21 FY4/22 FY4/23 YoY YoY （¥ million） results results plan change change(%) Net sales 297,305 316,

  12. Slide 12: Review

    Review © 2022 AIN HOLDINGS INC. All Rights Reserved. 11

  13. Slide 13: Daily new COVID-19 cases across Japan

    Daily new COVID-19 cases across Japan As of June 7, the number of domestic cases of the COVID-19 infection and deaths was 8,975,339 and 30,803, respectively. （people） Feb.1 110,000 103,701 100,000 Tokyo Olympics Tokyo Paralympics 90,000 Jul.23－Aug.8 Aug.24－Sep.5 80,000 pre-emergency state of emergen

  14. Slide 14: Review (YoY)

    Review (YoY) Ordinary profit increased ¥3.4 billion due to increase of net sales in dispensing pharmacy business. Net sales +¥18.9 billion Ordinary profit +¥3.4 billion ¥316.2 billion +6.4% ¥297.3 billion ¥16.0 billion +26.8% ¥12.6 billion ■Dispensing Dispensing Pharmacy Net sales Dispensing Dispens

  15. Slide 15: Strategy

    Strategy © 2022 AIN HOLDINGS INC. All Rights Reserved. 15

  16. Slide 16: Strategy

    Strategy Expansion of top-line and increase profits ■Dispensing Pharmacy Plan to open 160 pharmacies（Organic 48, M&A 112） ■Cosmetic and Drug Store Plan to open 10 stores Recruiting and training of human resources ■Planning to hire 600 newly graduated pharmacists（hired 660 new pharmacists in FY4/22）

  17. Slide 17: Expansion of top-line and increase profits 1

    Expansion of top-line and increase profits１ ■ Top-line ¥297.3 billion +6.4% ¥316.2 billion +14.8%¥363.0 billion ■Dispensing Pharmacy ¥263.0 billion ¥283.1 billion ¥326.0 billion ■Cosmetic and Drug store ¥19.4 billion ¥20.5 billion ¥24.7 billion ■Others ¥14.8 billion ¥12.6 billion ¥12.3 billion 400.0

  18. Slide 18: Expansion of top-line and increase profits 2

    Expansion of top-line and increase profits 2 FY4/22 Results FY4/23 Plan 1,177 1,332 Dispensing 1,099 Dispensing 1,249 114 Pharmacies Pharmacies Cosmetics and Cosmetics and 18 78 Drug stores 83 Drug stores 165 1 482 115 44 139 2 167 2 9 67 7 :Dispensing Pharmacies ：Cosmetic and drug stores © 2022 AIN

  19. Slide 19: Expansion of top-line and increase profits: openings and closures

    Expansion of top-line and increase profits 3 ■ Plan FY4/22 FY4/23 Plan Results Plan Dispensing Pharmacy 80 49 160 Organic 40 25 48 Opening 40 24 112 M&A 10 Cosmetic and drug store 15 12 170 Total 95 61 Dispensing Pharmacy 5 15 10 Closure Cosmetic and drug store 2 3 5 Total 7 18 15 Dispensing Pharmac

  20. Slide 20: Recruiting and training of human resources

    Recruiting and training of human resources In April 2022, new 660 pharmacists has joined our group. We aim to hire roughly the same number in fiscal 2023. As of April 30,2022, the group has 5,768 pharmacists out of 13,009 employees. （people） （people） 800 No. of newly-hired pharmacists 6000 5,230 No.

  21. Slide 21: Sustainability Management

    Sustainability Management We have conducted our corporate activities with common sense and ethics in order to realize our group statement of “the health and happiness of our customers" through our businesses contributing to people's health and beauty. Going forward, we will achieve sustainable corpo

  22. Slide 22: AINZ & TULPE stores opened in FY4/22

    AINZ & TULPE 1 AINZ & TULPE ■ in Fukuoka opened in FY4/22 12 stores LACHIC FUKUOKA TENJIN (October, 2021) LaLaport FUKUOKA FUKUOKA TENJIN-NISHI (April,2022) DORI (March,2022) ■ in Kagoshima CenTerrace TENMONKAN AMU PLAZA KAGOSHIMA (April,2022) (October, 2021) © 2022 AIN HOLDINGS INC. All Rights Rese

  23. Slide 23: AINZ & TULPE stores planned for FY4/23

    AINZ & TULPE 2 AINZ & TULPE plan to open in FY4/23 10 stores MOSAICMALL Kohoku KOBE MOTOMACHI (Opened in May 2022) (Opened in June 2022) Tokyo Tokyo (Plan to open in (Plan to open in October 2022) November 2022) © 2022 AIN HOLDINGS INC. All Rights Reserved. 23

  24. Slide 24: FY4/23 Plan (Consolidated)

    FY4/23 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2023 of ¥363,000 million, increase 14.8% YoY and ordinary profit of ¥20,500 million, increase 27.8% YoY. FY4/21 FY4/22 FY4/23 YoY YoY （¥ million） results results plan change change(%) Net sales 297,305 316,

  25. Slide 25: AIN Holdings Inc. Corporate Planning Division

    Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document ha

  26. Slide 26: AIN GROUP

    AIN GROUP

Ain Holdings — FY4/22 Earnings Presentation on 6ix